Literature DB >> 11194317

New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.

P O Coffin1, B P Linas, S H Factor, D Vlahov.   

Abstract

In May 2000, New York State passed legislation permitting the sale, purchase, and possession of up to 10 needles and syringes (hereafter "syringes") without a prescription, intended to reduce blood-borne pathogen transmission among injection drug users (IDUs). To obtain baseline data on pharmacists' attitudes and practices related to human immunodeficiency virus (HIV) prevention and IDUs, a telephone survey was administered to 130 pharmacists systematically selected in New York City. Less than half of pharmacists were aware of the new law; 49.6% were willing to or supported providing nonprescription sales of syringes to IDUs. Pharmacists in support tended to be less likely to consider customer appearance "very important." Managing and supervising pharmacists were more likely than staff pharmacists to support syringe sales to IDUs. Managing and supervising pharmacists who stocked packs of 10 syringes and personal sharps disposal containers, pharmacists who supported syringe exchange in the pharmacy, and pharmacists who were willing to sell syringes to diabetics without a prescription were more likely to support syringe sales to IDUs. Syringe disposal was a prominent concern among all pharmacists. Those not in support of syringe sales to IDUs tended to be more likely to believe the practice would increase drug use. These data suggest the need for initiatives to address concerns about syringe disposal and tailored continuing education classes for pharmacists on HIV and viral hepatitis prevention among IDUs.

Entities:  

Mesh:

Year:  2000        PMID: 11194317      PMCID: PMC3456774          DOI: 10.1007/BF02344038

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  11 in total

1.  HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic.

Authors:  D C Des Jarlais; M Marmor; P Friedmann; S Titus; E Aviles; S Deren; L Torian; D Glebatis; C Murrill; E Monterroso; S R Friedman
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

2.  New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation.

Authors:  B P Linas; P O Coffin; G Backes; D Vlahov
Journal:  J Urban Health       Date:  2000-12       Impact factor: 3.671

3.  An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.

Authors:  P Lurie; R Gorsky; T S Jones; L Shomphe
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

4.  Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws.

Authors:  A A Gleghorn; G Gee; D Vlahov
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

5.  Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.

Authors:  L Wright-De Agüero; B Weinstein; T S Jones; J Miles
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

6.  Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales.

Authors:  J Sheridan; J Strang; N Barber; A Glanz
Journal:  BMJ       Date:  1996-08-03

7.  Requests made in community pharmacies.

Authors:  L S Linn; D Lawrence
Journal:  Am J Public Health       Date:  1978-05       Impact factor: 9.308

Review 8.  Syringe availability as HIV prevention: a review of modalities.

Authors:  P Coffin
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

9.  Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers--Connecticut, 1992-1993.

Authors:  S L Groseclose; B Weinstein; T S Jones; L A Valleroy; L J Fehrs; W J Kassler
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-09-01

10.  HIV incidence among injecting drug users in New York City syringe-exchange programmes.

Authors:  D C Des Jarlais; M Marmor; D Paone; S Titus; Q Shi; T Perlis; B Jose; S R Friedman
Journal:  Lancet       Date:  1996-10-12       Impact factor: 79.321

View more
  14 in total

1.  Expanded syringe access demonstration program in New York State: an intervention to prevent HIV/AIDS transmission.

Authors:  S J Klein; G S Birkhead; A R Candelas
Journal:  J Urban Health       Date:  2000-12       Impact factor: 3.671

2.  What do pharmacists think about New York state's new nonprescription syringe sale program? Results of a survey.

Authors:  S J Klein; K Harris-Valente; A R Candelas; M Radigan; M Narcisse-Pean; J M Tesoriero; G S Birkhead
Journal:  J Urban Health       Date:  2001-12       Impact factor: 3.671

3.  Addressing urban health in Detroit, New York City, and Seattle through community-based participatory research partnerships.

Authors:  Marilyn M Metzler; Donna L Higgins; Carolyn G Beeker; Nicholas Freudenberg; Paula M Lantz; Kirsten D Senturia; Alison A Eisinger; Edna A Viruell-Fuentes; Bookda Gheisar; Ann-Gel Palermo; Donald Softley
Journal:  Am J Public Health       Date:  2003-05       Impact factor: 9.308

4.  Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.

Authors:  Nickolas Zaller; Alexandra Jeronimo; Jeffrey Bratberg; Patricia Case; Josiah D Rich
Journal:  J Urban Health       Date:  2010-12       Impact factor: 3.671

5.  Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.

Authors:  Robin A Pollini
Journal:  J Am Pharm Assoc (2003)       Date:  2017-08-12

6.  Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities.

Authors:  Leo Beletsky; Robin Ruthazer; Grace E Macalino; Josiah D Rich; Litjen Tan; Scott Burris
Journal:  J Urban Health       Date:  2007-01       Impact factor: 3.671

7.  Three years after legalization of nonprescription pharmacy syringe sales in California: where are we now?

Authors:  Richard S Garfein; Thomas J Stopka; Patricia B Pavlinac; Alessandra Ross; B Karen Haye; Elise D Riley; Ricky N Bluthenthal
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

8.  Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Katri Abel-Ollo; Ave Talu; Don Des Jarlais
Journal:  J Urban Health       Date:  2009-11-18       Impact factor: 3.671

9.  Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Katri Abel-Ollo; Ave Talu; Kristi Rüütel; Don C Des Jarlais
Journal:  Harm Reduct J       Date:  2009-02-20

10.  A national physician survey on prescribing syringes as an HIV prevention measure.

Authors:  G E Macalino; D Dhawan Sachdev; J D Rich; C Becker; L J Tan; L Beletsky; S Burris
Journal:  Subst Abuse Treat Prev Policy       Date:  2009-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.